Author

Jordan A. Stinson

Koch Institute for Integrative Cancer Research At MITORCID 0000-0003-3281-3172Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:proteomics· 2

Frequent Co-Authors

Elizabeth FinkiD· 3 shared Karl Dane WittrupiD· 3 shared Lauren DuhameliD· 2 shared William Pinney· 2 shared Allison M. SheeniD· 1 shared Anna M. RomanoviD· 1 shared Darrell J. IrvineiD· 1 shared David KrumiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

Elizabeth FinkORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioengineeringbioRxivPreprintApr 8, 2026

Engineering hyaluronic acid-binding cytokines for enhanced tumor retention and safety

Elizabeth Fink, William Pinney, Lauren Duhamel…·Karl Dane Wittrup

This study compares hyaluronic acid and collagen anchoring strategies for cytokine delivery, finding hyaluronic acid improves tumor retention and safety.

DOI 10.64898/2026.04.06.716711

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintJul 29, 2025

CD45 sequestration lowers the signaling threshold in lymphocytes and enhances anti-tumor immunity

Lauren Duhamel, Yiming J. Zhang, William Pinney…·Karl Dane Wittrup

This study shows that CD45 sequestration lowers T cell activation thresholds and enhances anti-tumor immunity when combined with IL-12 therapy in mouse models.

DOI 10.1101/2025.07.29.667400

mouseproteomics

𝕏 PostBluesky

Cancer BiologyClinical Cancer ResearchPeer-reviewedJul 9, 2024

Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogs

Jordan A. Stinson, Matheus Moreno P. Barbosa, Allison M. Sheen…·Timothy M. Fan

This study evaluates collagen-binding IL-2 and IL-12 in pet dogs with melanoma, showing local and regional therapeutic responses that suggest potential human clinical benefit.

17 citationstop 1%

experimental assaydrug response / drug discovery

𝕏 PostBluesky